HALOPERIDOL

Question 0

MECHANISM OF ACTION

Answer 0

MESOLINBIC D1/D2 ANTAGONIST DEPRESSES RELEASE OF HYPOTHALAMIC AND HYOPHYSEAL HORMONES; DEPRESSES THE RETICULAR ACTIVATING SYSTEM, AFFECTING BASAL METABOLISM, BODY TEMP WAKEFULNESS VASOMOTOR TOME AND EMESIS.

Question 1

DRUG CLASSIFICATION

Answer 1

BUTYROPHENONE ANTIPSYCHOTIC/NEUROLEPTIC

Question 2

PHARMACOKINTETICS

Answer 2

ONSET 30-45 M
PEAK EFFECTS 10-20M
DUTATION-VARIES
HALF LIFE 3-35 H

Question 3

INDICATIONS FIELD USE

Answer 3

acute psychotic episode

Question 4

contraindications

Answer 4

cns DEPRESSION

AGITATIN SECONDARY T SHOCK OR HYPOXIA

Question 5

SIDE EFFECTS/ ADVERSE REACTIONS

Answer 5

EPS, INSOMNIA RESTLESSNESS, DROWSINESS, SEIZURES, DRY MOUTH, CONSTIPATION, RESPIRATORY DEPRESSION, TACHCARDIA, HYPOTENSION, PROLONGED QT SYNDROME, TORSADES

Question 6

DOSE

Answer 6

ADULT 5 MG Q 4-8H PRN

KIDS 1-3MG IM Q4-8H PRN MAX 0.15MG/KG/DAY

Question 7

PRECAUTIONS

Answer 7

MAYIMPAR PHYSICAL AND MENTAL ABILITIES MAY CAUSE ORTHOSTATIC HYPOTENSION MAY CAUSE EPS-DYSTONIC REACTION.

Question 8

DRUG-DRUG

Answer 8

CAUTION IN PATIENTS TAKING LITHIUM, MAY CAUSE ENCEPHALOPATHIC SYNDROME (BRAIN DAMAGE)

MAY INCREASE CHANCE OF HYPOTENSION WHEN TAKEN WITH ANTIHYPERTENSIVES ADDITIVE EFFECTS WITH DEPRESSANTS AND OTHER ANTI PSYCHOTICS INCREASED CNS DEPRESSION